Page last updated: 2024-09-05

varenicline and Idiopathic Parkinson Disease

varenicline has been researched along with Idiopathic Parkinson Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Abreu-Villaça, Y; Araújo, UC; Filgueiras, CC; Isnardo-Fernandes, J; Leal-Rocha, PH; Manhães, AC; Ribeiro-Carvalho, A1
Albin, RL; Bohnen, NI; Dauer, WT; Kim, K; Koeppe, RA; Lustig, C; Müller, MLTM; Sarter, M; Spino, C; Szpara, A1
Açikalin, Ö; Bölükbaşi Hatip, F; Hatip-Al-Khatib, I; Kataoka, Y; Tan, R; Yamauchi, A1
Kaakkola, S; Tuominen, R1
Campos, C; Huang, LZ; Ivy Carroll, F; Ly, J; Quik, M1

Reviews

1 review(s) available for varenicline and Idiopathic Parkinson Disease

ArticleYear
[Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].
    Duodecim; laaketieteellinen aikakauskirja, 2013, Volume: 129, Issue:16

    Topics: Alzheimer Disease; Ataxia; Benzazepines; Cognitive Dysfunction; Epilepsy, Frontal Lobe; Humans; Mutation; Nicotine; Nicotinic Agonists; Parkinson Disease; Quinoxalines; Receptors, Nicotinic; Tobacco Use Cessation Devices; Varenicline

2013

Other Studies

4 other study(ies) available for varenicline and Idiopathic Parkinson Disease

ArticleYear
Exposure to varenicline protects against locomotor alteration in a MPTP mouse model of Parkinson's disease.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2021, Volume: 54, Issue:12

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Varenicline

2021
α4β2
    Annals of neurology, 2021, Volume: 90, Issue:1

    Topics: Aged; Brain; Cross-Over Studies; Female; Gait; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Nicotinic Agonists; Parkinson Disease; Positron-Emission Tomography; Postural Balance; Varenicline

2021
Effect of varenicline on behavioral deficits in a rat model of Parkinson's disease induced by unilateral 6-hydroxydopamine lesion of substantia nigra.
    Behavioural pharmacology, 2018, Volume: 29, Issue:4

    Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Male; Motor Activity; Nicotinic Agonists; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substantia Nigra; Varenicline

2018
Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.
    Neuropharmacology, 2011, Volume: 60, Issue:6

    Topics: Animals; Antiparkinson Agents; Azetidines; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Levodopa; Male; Nicotinic Agonists; Oxidopamine; Parkinson Disease; Quinoxalines; Rats; Rats, Sprague-Dawley; Varenicline

2011